 (CHEST 1998; 113:964-67) 
Other potential predictors of asthma exacerbation, eg, atopy, duration and dose of ICS treatment, lung function, and bronchial responsiveness at diagnosis, were also investigated, but none was shown to be significantly related with the occurrence of asthma exacerbation.
In conclusion, this study shows that withdrawing treatment with ICS when bronchial responsiveness is normal does not reduce the likelihood of asthma exacerbation, but the exacerbation may be delayed.
These results need to be confirmed in studies on larger numbers of patients.
